Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Capital Leases (2019 - 2025)

Marimed has reported Capital Leases over the past 7 years, most recently at $2.0 million for Q4 2025.

  • Quarterly Capital Leases rose 1.56% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, up 1.56% year-over-year, with the annual reading at $2.0 million for FY2025, 1.56% up from the prior year.
  • Capital Leases was $2.0 million for Q4 2025 at Marimed, down from $2.2 million in the prior quarter.
  • Over five years, Capital Leases peaked at $2.7 million in Q2 2024 and troughed at $22000.0 in Q4 2021.
  • The 5-year median for Capital Leases is $1.6 million (2023), against an average of $1.3 million.
  • Year-over-year, Capital Leases crashed 50.55% in 2021 and then surged 1995.45% in 2022.
  • A 5-year view of Capital Leases shows it stood at $22000.0 in 2021, then surged by 1995.45% to $461000.0 in 2022, then soared by 364.21% to $2.1 million in 2023, then dropped by 10.0% to $1.9 million in 2024, then rose by 1.56% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Capital Leases are $2.0 million (Q4 2025), $2.2 million (Q3 2025), and $2.2 million (Q2 2025).